Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
Injecting plant-based nanoparticles and chemotherapy drug helps halt tumor progression in mice

Injecting plant-based nanoparticles and chemotherapy drug helps halt tumor progression in mice

New cancer drug shows promise to treat leukemia in mouse models

New cancer drug shows promise to treat leukemia in mouse models

Immunotherapy combination offers new hope for women with early stage triple negative breast cancer

Immunotherapy combination offers new hope for women with early stage triple negative breast cancer

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

WSU scientists develop new approach to deliver therapeutics to tumors

WSU scientists develop new approach to deliver therapeutics to tumors

Study finds no clear benefit of stem-cell transplant for double-hit lymphoma patients in remission

Study finds no clear benefit of stem-cell transplant for double-hit lymphoma patients in remission

UAB symposium highlights use of tissue engineering to repair broken hearts

UAB symposium highlights use of tissue engineering to repair broken hearts

Short-term fasting during chemotherapy may counteract side effects of common cancer drugs

Short-term fasting during chemotherapy may counteract side effects of common cancer drugs

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

Metabolic vulnerability in triple-negative breast cancer cells may help quell chemotherapy resistance

Metabolic vulnerability in triple-negative breast cancer cells may help quell chemotherapy resistance

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

Timing of chemotherapy can have big effect on inflammation, study shows

Timing of chemotherapy can have big effect on inflammation, study shows

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Researchers develop innovative method to manufacture biocompatible implantable microdevices

Researchers develop innovative method to manufacture biocompatible implantable microdevices

ESMO Asia 2016: Three studies present first data on rare sarcomas in Asian patients

ESMO Asia 2016: Three studies present first data on rare sarcomas in Asian patients

Japanese researchers discover that 2-aminobutyric acid can effectively raise antioxidant levels

Japanese researchers discover that 2-aminobutyric acid can effectively raise antioxidant levels

Antioxidant levels could be boosted with newly-found amino acid function

Antioxidant levels could be boosted with newly-found amino acid function

FDA approves new combo treatment for patients with advanced sarcomas

FDA approves new combo treatment for patients with advanced sarcomas

NUS researchers identify molecular switch that makes breast cancer cells more aggressive

NUS researchers identify molecular switch that makes breast cancer cells more aggressive

Heart problems from common cancer treatment can be alleviated by using gene therapy

Heart problems from common cancer treatment can be alleviated by using gene therapy